For investors, this could be an intriguing opportunity to gain exposure to quality companies at a historic discount.\u00a0<\/p>\n
Here are three of the largest ASX healthcare stocks that are tipped to rebound from historic lows.\u00a0<\/p>\n
![\"Beautiful](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/02\/thinking-about-juicy-dividends-16.9-1200x675.jpg\")
<\/p>\n
Image source: Getty Images<\/p>\n
Pro Medicus Ltd (ASX: PME<\/a>)<\/p>\n Pro Medicus enjoyed a fast start to the month of June.\u00a0<\/p>\n The medical imaging technology company rose over 9% yesterday following a key contract win<\/a>.<\/p>\n Investors will be hoping this is the start of a long-term rebound.\u00a0<\/p>\n Despite yesterday’s 9% gain, it remains down 35% year to date.\u00a0<\/p>\n It closed yesterday at $144.46 per share.\u00a0<\/p>\n However brokers are confident it will rise significantly higher in the next 12 months.\u00a0<\/p>\n 13 analysts offering a one year forecast have an average price target of $187.27 on Pro Medicus shares, indicating roughly 3% upside from current levels.\u00a0<\/p>\n 11 of the 13 analysts rate the stock as a strong buy or buy.\u00a0<\/p>\n While Pro Medicus shares started June off with a big rise, it was the opposite start to the month for ResMed shares.\u00a0<\/p>\n ResMed is a global leader in sleep technology.<\/p>\n Its share price fell more than 7% yesterday, and is now down 26% year to date.\u00a0<\/p>\n It now sits at a new 52-week low<\/a> of $26.27.\u00a0<\/p>\n However this could now be a rare opportunity to scoop up this ASX healthcare stock at a significant value.\u00a0<\/p>\n